Portugal, C., Fang, M. C., Go, A. S., Zhou, H., Chang, J., Prasad, P., . . . Reynolds, K. (2022). The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results. PloS one, 17(12), e0277961. https://doi.org/10.1371/journal.pone.0277961
Citace podle Chicago (17th ed.)Portugal, Cecilia, et al. "The Anticoagulation Length of Therapy and Risk of New Adverse Events in Venous Thromboembolism (ALTERNATIVE) Study: Design and Survey Results." PloS One 17, no. 12 (2022): e0277961. https://doi.org/10.1371/journal.pone.0277961.
Citace podle MLA (9th ed.)Portugal, Cecilia, et al. "The Anticoagulation Length of Therapy and Risk of New Adverse Events in Venous Thromboembolism (ALTERNATIVE) Study: Design and Survey Results." PloS One, vol. 17, no. 12, 2022, p. e0277961, https://doi.org/10.1371/journal.pone.0277961.